The FDA has cleared the QIAGEN anus C. difficile QS-RGQ MDx Kit, developed by IMDx, for use in the US. This kit aids in diagnosing Clostridium difficile infections. The QlAsymphony RGQ MDx System, which integrates automated sample preparation and assay setup, was also cleared. IMDx and QIAGEN are expanding their test menu, including tests for Herpes Simplex Viruses and Group B Streptococcus.
documents/EFTA00605649.pdf
{}